# Elicio Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 7, 2025

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-07
- Accepted by EDGAR: Mar 7, 2025, 21:07 ET
- Period: not reported
- Accession: 0000950170-25-035497
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000095017025035497/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000095017025035497/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000095017025035497/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 7, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-035497. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.